Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Immucell Cp (ICCC)

Immucell Cp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2022

Conference Call Scheduled for Friday, August 12, 2022 at 9:00 AM ET...

ICCC : 5.14 (+0.78%)
ImmuCell Receives Technical Section Incomplete Letter from FDA Pertaining to Re-Tain®

PORTLAND, Maine, July 27, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company...

ICCC : 5.14 (+0.78%)
ImmuCell Announces Preliminary, Unaudited Sales Results for Second Quarter of 2022

PORTLAND, Maine, July 07, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company...

ICCC : 5.14 (+0.78%)
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2022

Q1 2022 Product Sales Increased 46% over Q1 2021...

ICCC : 5.14 (+0.78%)
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2022

Conference Call Scheduled for Friday, May 13, 2022 at 9:00 AM ET...

ICCC : 5.14 (+0.78%)
UPDATE -- Dr. Mark Wustenberg joins ImmuCell as Commercial Leader of Stakeholder Engagement

PORTLAND, Maine, May 05, 2022 (GLOBE NEWSWIRE) -- Certain immaterial corrections have been made to the second and fifth paragraphs. ImmuCell Corporation...

ICCC : 5.14 (+0.78%)
Dr. Mark Wustenberg joins ImmuCell as Commercial Leader of Stakeholder Engagement

PORTLAND, Maine, May 05, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that...

ICCC : 5.14 (+0.78%)
ImmuCell Announces Record Preliminary, Unaudited Sales Results for First Quarter of 2022

PORTLAND, Maine, April 11, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company...

ICCC : 5.14 (+0.78%)
ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2021

Annual Product Sales for 2021 Increased 25% over 2020...

ICCC : 5.14 (+0.78%)
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2021

Conference Call Scheduled for Wednesday, February 23, 2022 at 9:00 AM ET...

ICCC : 5.14 (+0.78%)

Barchart Exclusives

3 Highest-Yielding (And Safest) Dividend Aristocrats To Buy Today
The highest-yielding dividend aristocrats aren't always the safest stocks to buy. Here's what I did to counteract this. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar